Literature DB >> 24966076

Biological markers in haematological malignancies.

Richard Lemal1, Olivier Tournilhac1, Jacques-Olivier Bay1.   

Abstract

Haematological malignancies comprise a wide spectrum of well-defined entities, and require a risk-adapted treatment. Beside the classical diagnostic tools, haematologists have routinely access to more and more biological markers, which provide different informations about diagnosis, prognosis and targetable status of each individual disease and permit to define a personalized risk-adapted therapeutic strategy. We aim to describe these different biological markers and to pinpoint their accurate role in daily practice.

Entities:  

Keywords:  biology; diagnosis; haematology; prognosis

Mesh:

Substances:

Year:  2014        PMID: 24966076     DOI: 10.1684/bdc.2014.1974

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  1 in total

1.  Advanced lymphoblastic clones detection in T-cell leukemia.

Authors:  A A Minervina; A Y Komkov; I Z Mamedov; Y B Lebedev
Journal:  Dokl Biochem Biophys       Date:  2016-05-20       Impact factor: 0.788

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.